Endra Life Sciences GAAP EPS of -$0.05

Nov. 14, 2022 4:49 PM ETENDRA Life Sciences Inc. (NDRA)By: Ahmed Farhath, SA News Editor
  • Endra Life Sciences press release (NASDAQ:NDRA): Q3 GAAP EPS of -$0.05.
  • Operating expenses increased to $3.4 million in the third quarter of 2022 from $2.7 million in the same period in 2021. The increase was primarily due to higher spending related to commercializing the TAEUS system and ongoing product development.
  • Cash and cash equivalents were $8.0 million as of September 30, 2022.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.